Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 109

1.

Impact of the N-terminal secretor domain on YopD translocator function in Yersinia pseudotuberculosis type III secretion.

Amer AA, Åhlund MK, Bröms JE, Forsberg Å, Francis MS.

J Bacteriol. 2011 Dec;193(23):6683-700. doi: 10.1128/JB.00210-11.

2.

Coiled-coils in the YopD translocator family: a predicted structure unique to the YopD N-terminus contributes to full virulence of Yersinia pseudotuberculosis.

Costa TR, Amer AA, Fällman M, Fahlgren A, Francis MS.

Infect Genet Evol. 2012 Dec;12(8):1729-42. doi: 10.1016/j.meegid.2012.07.016.

PMID:
22910185
3.

YopD self-assembly and binding to LcrV facilitate type III secretion activity by Yersinia pseudotuberculosis.

Costa TR, Edqvist PJ, Bröms JE, Ahlund MK, Forsberg A, Francis MS.

J Biol Chem. 2010 Aug 13;285(33):25269-84. doi: 10.1074/jbc.M110.144311.

4.

Yersinia pseudotuberculosis YopD mutants that genetically separate effector protein translocation from host membrane disruption.

Adams W, Morgan J, Kwuan L, Auerbuch V.

Mol Microbiol. 2015 May;96(4):764-78. doi: 10.1111/mmi.12970.

5.

Functional conservation of the effector protein translocators PopB/YopB and PopD/YopD of Pseudomonas aeruginosa and Yersinia pseudotuberculosis.

Frithz-Lindsten E, Holmström A, Jacobsson L, Soltani M, Olsson J, Rosqvist R, Forsberg A.

Mol Microbiol. 1998 Sep;29(5):1155-65.

7.
8.

Inflammasome activation in response to the Yersinia type III secretion system requires hyperinjection of translocon proteins YopB and YopD.

Zwack EE, Snyder AG, Wynosky-Dolfi MA, Ruthel G, Philip NH, Marketon MM, Francis MS, Bliska JB, Brodsky IE.

MBio. 2015 Feb 17;6(1):e02095-14. doi: 10.1128/mBio.02095-14.

9.

Type III secretion translocon assemblies that attenuate Yersinia virulence.

Costa TR, Amer AA, Farag SI, Wolf-Watz H, Fällman M, Fahlgren A, Edgren T, Francis MS.

Cell Microbiol. 2013 Jul;15(7):1088-110. doi: 10.1111/cmi.12100.

PMID:
23279117
11.

The YopD translocator of Yersinia pseudotuberculosis is a multifunctional protein comprised of discrete domains.

Olsson J, Edqvist PJ, Bröms JE, Forsberg A, Wolf-Watz H, Francis MS.

J Bacteriol. 2004 Jul;186(13):4110-23.

12.

Random mutagenesis identifies a C-terminal region of YopD important for Yersinia type III secretion function.

Solomon R, Zhang W, McCrann G, Bliska JB, Viboud GI.

PLoS One. 2015 Mar 25;10(3):e0120471. doi: 10.1371/journal.pone.0120471. Erratum in: PLoS One. 2015;10(6):e0130112.

13.

Minimal YopB and YopD translocator secretion by Yersinia is sufficient for Yop-effector delivery into target cells.

Edqvist PJ, Aili M, Liu J, Francis MS.

Microbes Infect. 2007 Feb;9(2):224-33.

PMID:
17223369
14.

Yersinia YopE is targeted for type III secretion by N-terminal, not mRNA, signals.

Lloyd SA, Norman M, Rosqvist R, Wolf-Watz H.

Mol Microbiol. 2001 Jan;39(2):520-31.

15.
16.

Yersinia pestis YopD 150-287 fragment is partially unfolded in the native state.

Raab R, Swietnicki W.

Protein Expr Purif. 2008 Mar;58(1):53-60.

PMID:
18160307
18.

YopK of Yersinia pseudotuberculosis controls translocation of Yop effectors across the eukaryotic cell membrane.

Holmström A, Petterson J, Rosqvist R, Håkansson S, Tafazoli F, Fällman M, Magnusson KE, Wolf-Watz H, Forsberg A.

Mol Microbiol. 1997 Apr;24(1):73-91.

19.

YopB and YopD constitute a novel class of Yersinia Yop proteins.

Håkansson S, Bergman T, Vanooteghem JC, Cornelis G, Wolf-Watz H.

Infect Immun. 1993 Jan;61(1):71-80.

Supplemental Content

Support Center